Company Info
| Phone: | (410) 522-8707 |
| Year Established: | 2011 |
| Ticker: | AVTX |
| Exchange: | NASDAQ |
Contacts
| Primary: | Garry Neil, MD Chair & CEO |
| Other: | Chris Sullivan CFO Paul Varki CLO Mittie Doyle, MD, FACR CMO Jennifer Riley Chief Strategy Officer |
Company Description
Avalo Therapeutics, formerly Cerecor & Aevi Genomic, is a clinical stage biotechnology company focused on the treatment of immune dysregulation by developing therapies that target the LIGHT-signaling network.
